Trials / Completed
CompletedNCT01571453
Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
Randomised, Double-blind, Parallel-group, Active-comparator (Venlafaxine Extended Release), Fixed-dose Study of [Vortioxetine] Lu AA21004 in Major Depressive Disorder in Asian Countries
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 437 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted with the aim of investigating the efficacy, safety and tolerability of 10 mg/day Vortioxetine in Asian patients compared to an approved active comparator (venlafaxine extended release 150 mg/day).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vortioxetine (Lu AA21004) | 10 mg/day |
| DRUG | Venlafaxine extended release | 150 mg/day |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-10-01
- First posted
- 2012-04-05
- Last updated
- 2014-10-13
- Results posted
- 2014-10-13
Source: ClinicalTrials.gov record NCT01571453. Inclusion in this directory is not an endorsement.